Parnassus Investments
AZN icon

Parnassus Investments’s AstraZeneca AZN Stock Holding History

Parnassus Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119M Sell
629,158
-12,980
-2% -$2.44M 0.32% 52
2026
Q1 		$127M Buy
642,138
+23,278
+4% +$4.49M 0.37% 46
2025
Q4 		$114M Sell
618,860
-27,642
-4% -$4.85M 0.3% 50
2025
Q3 		$99.2M Buy
646,502
+3,012
+0.5% +$456K 0.23% 58
2025
Q2 		$89.9M Buy
643,490
+31,110
+5% +$4.36M 0.21% 62
2025
Q1 		$90M Buy
612,380
+22,871
+4% +$3.31M 0.22% 67
2024
Q4 		$77.2M Buy
589,509
+585,806
+15,820% +$82M 0.17% 84
2024
Q3 		$577K Sell
3,703
-1,303
-26% -$210K ﹤0.01% 126
2024
Q2 		$781K Buy
5,006
+200
+4% +$30.1K ﹤0.01% 124
2024
Q1 		$651K Buy
4,806
+2,485
+107% +$329K ﹤0.01% 130
2023
Q4 		$313K Buy
2,321
+658
+40% +$85.5K ﹤0.01% 128
2023
Q3 		$225K Sell
1,663
-687
-29% -$93.8K ﹤0.01% 137
2023
Q2 		$336K Sell
2,350
-566
-19% -$83.3K ﹤0.01% 126
2023
Q1 		$405K Buy
2,916
+963
+49% +$130K ﹤0.01% 120
2022
Q4 		$265K Buy
+1,953
New +$245K ﹤0.01% 129

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parnassus Investments's AZN Position: Q2 2026 in Review

Parnassus Investments reduced its AstraZeneca (AZN) stake by 2% in Q2 2026, selling an estimated $2.44M and leaving 629,158 shares worth $119M. The position accounts for 0.32% of the portfolio, ranked #52.

Parnassus Investments first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $127M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Parnassus Investments held 629,158 shares of AstraZeneca worth $119M as of Q2 2026.
  • Parnassus Investments sold 12,980 AstraZeneca shares in Q2 2026, an estimated $2.44M.
  • AstraZeneca made up 0.32% of Parnassus Investments's portfolio in Q2 2026, its #52 holding.
  • Parnassus Investments first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
  • Parnassus Investments's AstraZeneca position peaked at $127M in Q1 2026.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.